Eupraxia Pharmaceuticals Inc. Common share purchase warrants


By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to approved drugs. Its product candidates address therapeutic areas with a high unmet medical need and strive to provide improved patient benefit by delivering targeted, long-lasting activity with fewer side effects. Its lead product candidate, EP-104IAR, is in development for the treatment of pain due to osteoarthritis of the knee. In addition, it is developing a pipeline of earlier-stage long-acting formulations.

Contact Information

Main Phone: +1 250 590-3968
Address: 204 - 2590 Cadboro Bay
State: BC
City / Town: Victoria
Country: CA

Issuer Information

Exchange: TSX
CEO: James A. Helliwell
Employees: 12
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)(541714)

Equities News

Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A